A pair of University of Lethbridge epigenetics researchers, Drs. Olga and Igor Kovalchuk, argued high-CBD tinctures (not commercially available) could be used to protect mouth, lung, and intestinal tissues from allowing COVID-19 transmission.
CTV News, Stockhouse
- Their theory is based on preliminary data and requires additional research, but the Kovalchuks are legitimate, award-winning researchers and they’ve submitted their work to an unnamed journal for review.
- The US Food and Drug Administration has warned against unsubstantiated claims that CBD treats COVID-19, and the US Federal Trade Commission has cracked down on similar claims. Still, we can likely expect the very existence of this research to be misinterpreted by wingnuts.
Cannabis Industry Journal, WeedWeek, FTC
